Assyro AI

Orange Book product · Generic (ANDA)

NAFCILLIN SODIUM

NAFCILLIN SODIUM

Generic (ANDA)ANDA 090002TE APRX ISTITUTO BIO ITA SPA
View NAFCILLIN SODIUM familyOpen on FDA Orange Book

At a glance

Jun 30, 2011

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 30, 2011

    15 yr 2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

NAFCILLIN SODIUM

Strength

EQ 1GM BASE/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 090002

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of NAFCILLIN SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo